Procter & Gamble Company (The) $PG Shares Acquired by GAMMA Investing LLC

Posted by Francis Steltz on Aug 5th, 2026

GAMMA Investing LLC increased its position in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 11.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 60,218 shares of the company’s stock after purchasing an additional 6,169 shares during the period. GAMMA Investing LLC’s holdings in Procter & Gamble were worth $8,830,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in Procter & Gamble by 1.2% during the fourth quarter. Vanguard Group Inc. now owns 237,459,756 shares of the company’s stock valued at $34,030,358,000 after buying an additional 2,829,151 shares in the last quarter. State Street Corp raised its position in Procter & Gamble by 1.0% in the fourth quarter. State Street Corp now owns 101,618,926 shares of the company’s stock worth $14,563,008,000 after acquiring an additional 984,102 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Procter & Gamble by 3.3% in the 4th quarter. Geode Capital Management LLC now owns 62,647,882 shares of the company’s stock valued at $8,962,689,000 after acquiring an additional 1,974,556 shares during the last quarter. Norges Bank acquired a new stake in Procter & Gamble in the 4th quarter valued at about $4,664,783,000. Finally, Price T Rowe Associates Inc. MD boosted its position in shares of Procter & Gamble by 3.8% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 29,612,826 shares of the company’s stock valued at $4,243,815,000 after purchasing an additional 1,091,091 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Price Performance

NYSE PG opened at $147.99 on Wednesday. The company has a current ratio of 0.68, a quick ratio of 0.47 and a debt-to-equity ratio of 0.42. Procter & Gamble Company has a 1 year low of $137.62 and a 1 year high of $167.25. The company has a market cap of $344.61 billion, a PE ratio of 22.36, a PEG ratio of 4.45 and a beta of 0.39. The stock’s 50-day moving average price is $147.81 and its two-hundred day moving average price is $148.97.

Procter & Gamble (NYSE:PG – Get Free Report) last announced its earnings results on Wednesday, July 29th. The company reported $1.43 EPS for the quarter, topping the consensus estimate of $1.41 by $0.02. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.25%. The company had revenue of $21.20 billion during the quarter, compared to analysts’ expectations of $21.38 billion. During the same period last year, the company posted $1.48 earnings per share. The business’s revenue for the quarter was up 1.5% on a year-over-year basis. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. On average, analysts predict that Procter & Gamble Company will post 6.99 EPS for the current year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, August 17th. Shareholders of record on Friday, July 24th will be paid a dividend of $1.0885 per share. This represents a $4.35 annualized dividend and a yield of 2.9%. The ex-dividend date of this dividend is Friday, July 24th. Procter & Gamble’s payout ratio is 65.71%.

Analyst Upgrades and Downgrades

PG has been the topic of several recent research reports. Wells Fargo & Company lifted their price objective on shares of Procter & Gamble from $158.00 to $164.00 and gave the stock an “overweight” rating in a research note on Monday, April 27th. Citigroup cut their target price on shares of Procter & Gamble from $181.00 to $170.00 and set a “buy” rating for the company in a research note on Thursday, July 30th. Piper Sandler raised their target price on shares of Procter & Gamble from $142.00 to $145.00 and gave the stock a “neutral” rating in a report on Friday, April 24th. Bank of America decreased their price target on shares of Procter & Gamble from $170.00 to $166.00 and set a “buy” rating on the stock in a research report on Friday, July 10th. Finally, UBS Group increased their price objective on Procter & Gamble from $166.00 to $172.00 and gave the company a “buy” rating in a research report on Monday, April 27th. Thirteen equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $161.52.

Read Our Latest Report on Procter & Gamble

Trending Headlines about Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

Positive Sentiment: Strategic acquisition strengthens growth prospects. Thorne will complement P&G’s existing health brands, including Metamucil, Align Probiotic and New Chapter, while adding exposure to the premium wellness market. The deal is expected to close later this year. L Catterton Announces Sale of Thorne to The Procter & Gamble Company for $3.8 Billion
Positive Sentiment: Management is emphasizing healthcare growth. CEO Shailesh Jejurikar said the Thorne purchase is intended to grow P&G’s health business, and reports characterized the asset as a strong strategic fit. Investors may view the move as a way to diversify beyond slower-growing household and personal-care categories. Procter & Gamble will acquire supplements brand Thorne
Positive Sentiment: Input-cost pressure may be easing. Coverage points to cooling commodity and other input pressures, which could provide some relief to margins if the trend continues. Why Is Procter & Gamble in Focus as Input Pressures Cool?

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.